U.S. seeds and agrochemicals maker Monsanto Co. has secured approval from the U.S. Environmental Protection Agency for a new dicamba-based weed killer designed for its next generation biotech soy and cotton varieties, the company said on Wednesday. While approval had been expected, it is seen as a major step forward for the company’s newest herbicide […] Read more

EPA approves Monsanto’s dicamba weed killer

WHO cancer agency asked experts to withhold glyphosate documents
London | Reuters — The World Health Organization’s cancer agency — which is facing criticism over how it classifies carcinogens — advised academic experts on one of its review panels not to disclose documents they were asked to release under U.S. freedom of information laws. In a letter and an email seen by Reuters, officials […] Read more

ChemChina reported ready for concessions to clinch Syngenta deal
Beijing/Zurich | Reuters — State-owned Chinese chemicals group ChemChina is ready to offer more concessions to win European Union antitrust approval for its US$43 billion bid for Swiss pesticide and seed group Syngenta, a source with direct knowledge of the process said. Clinching China’s biggest-ever foreign acquisition is taking longer than planned amid a flurry […] Read more

Monsanto surprises with adjusted profit as expenses drop
Reuters — U.S. seeds and agrochemicals company Monsanto, which agreed last month to be bought by Germany’s Bayer for US$66 billion, reported a surprise adjusted profit, helped by a drop in expenses and higher corn seed volumes. Monsanto agreed in September to a sweetened $128-per-share offer from Bayer that, if approved by regulators, would create […] Read more

Agricultural merger mania fuels fears among small seed sellers
Chicago | Reuters — The U.S. Justice Department is looking into concerns that global consolidation among major seed and agricultural chemical companies may squeeze supplies of the building blocks for widely used genetically modified seeds, a farm group told Reuters. The department has asked the American Soybean Association for details about how small and independent […] Read more

U.S. lawmakers skeptical of ag chemical, seed merger wave
Washington | Reuters — U.S. lawmakers expressed concern on Tuesday over a wave of mergers among companies that sell farmers their seeds, herbicides and insecticides, worrying that the deals could lead to higher prices and less innovation at a time of dropping farm incomes. Senator Richard Blumenthal, a Democrat from Connecticut, said the proposed mergers […] Read more

U.S. EPA says glyphosate likely not carcinogenic
Chicago | Reuters — The U.S. Environmental Protection Agency on Friday said its current position on glyphosate, the key ingredient in Monsanto’s Roundup herbicide, is that the chemical is not likely carcinogenic to humans. The agency’s “proposed” position on the controversial chemical was outlined in a 227-page paper it published on the regulations.gov website, which […] Read more

Bayer betting billions farmers will back linked-up supplies
Frankfurt | Reuters — Bayer’s US$66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products. In the short term, the German drugs and chemicals firm hopes to benefit from a marketing and sales force […] Read more

Climate’s field software en route to Eastern Canada
San Francisco-based ag software firm and Monsanto subsidiary The Climate Corporation is making a run for the border with its Climate FieldView farm data suite. Appearing Wednesday at Canada’s Outdoor Farm Show, company representatives announced their suite of digital farm data tools, Climate FieldView, will be offered for sale in Eastern Canada this winter, for […] Read more

Bayer clinches Monsanto with raised US$66 billion bid
New York/Frankfurt | Reuters — German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of US$66 billion including debt, ending months of wrangling after increasing its bid for a third time. The $128 a share deal announced on Wednesday, up from Bayer’s previous offer of […] Read more